Six years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $75 million
Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance ...
Tag: biotech
Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. ...
Popular News
-
16 hijacked browser extensions expose 3.2 million users
-
That bank transfer alert text you received may be a scam
-
Peter Dutton defends attending Hemmes fundraiser as Cyclone Alfred approached Queensland
-
Pope Francis now eating solid foods, showing 'slight gradual improvements,' Vatican says
-
Jury is out on Rubio in Senate, as some lose faith
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!